These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

538 related items for PubMed ID: 8689881

  • 21. Omitting the first oral contraceptive pills of the cycle does not automatically lead to ovulation.
    Elomaa K, Rolland R, Brosens I, Moorrees M, Deprest J, Tuominen J, Lähteenmäki P.
    Am J Obstet Gynecol; 1998 Jul; 179(1):41-6. PubMed ID: 9704763
    [Abstract] [Full Text] [Related]

  • 22. The effects of desogestrel and ethinylestradiol combination in normal and hyperandrogenic young girls: speculations on contraception in adolescence.
    Venturoli S, Porcu E, Gammi L, Fabbri R, Paradisi R, Flamigni C, Patrono D, Capelli M, Paoletti C.
    Acta Eur Fertil; 1988 Jul; 19(3):129-34. PubMed ID: 2976224
    [Abstract] [Full Text] [Related]

  • 23. Oral contraceptives containing 20 or 30 micrograms ethinylestradiol and 150 micrograms desogestrel: pharmacokinetics and pharmacodynamic parameters.
    Jung-Hoffmann C, Fitzner M, Kuhl H.
    Horm Res; 1991 Jul; 36(5-6):238-46. PubMed ID: 1823082
    [Abstract] [Full Text] [Related]

  • 24. The effect of an oral contraceptive containing ethinylestradiol and desogestrel on hair growth and hormonal parameters of hirsute women.
    Ruutiainen K.
    Int J Gynaecol Obstet; 1986 Oct; 24(5):361-8. PubMed ID: 2880770
    [Abstract] [Full Text] [Related]

  • 25. Ovarian activity during regular oral contraceptive use.
    Crosignani PG, Testa G, Vegetti W, Parazzini F.
    Contraception; 1996 Nov; 54(5):271-3. PubMed ID: 8934059
    [Abstract] [Full Text] [Related]

  • 26. Influence of gestodene and desogestrel as components of low-dose oral contraceptives on the pharmacokinetics of ethinyl estradiol (EE2), on serum CBG and on urinary cortisol and 6 beta-hydroxycortisol.
    Hammerstein J, Daume E, Simon A, Winkler UH, Schindler AE, Back DJ, Ward S, Neiss A.
    Contraception; 1993 Mar; 47(3):263-81. PubMed ID: 8462317
    [Abstract] [Full Text] [Related]

  • 27. A comparative metabolic study of two low-estrogen-dose oral contraceptives containing desogestrel or gestodene progestins.
    Crook D, Godsland IF, Worthington M, Felton CV, Proudler AJ, Stevenson JC.
    Am J Obstet Gynecol; 1993 Nov; 169(5):1183-9. PubMed ID: 8238183
    [Abstract] [Full Text] [Related]

  • 28. Evidence that treatment with monophasic oral contraceptive formulations containing ethinylestradiol plus gestodene reduces bone resorption in young women.
    Paoletti AM, Orrù M, Floris S, Mannias M, Vacca AM, Ajossa S, Guerriero S, Melis GB.
    Contraception; 2000 Apr; 61(4):259-63. PubMed ID: 10899481
    [Abstract] [Full Text] [Related]

  • 29. Comparison of two monophasic oral contraceptives: gestodene/ethinyl estradiol versus desogestrel/ethinyl estradiol.
    Benagiano G.
    Int J Fertil; 1989 Sep; 34 Suppl():31-9. PubMed ID: 2576255
    [Abstract] [Full Text] [Related]

  • 30. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
    Teichmann A.
    Int J Fertil Menopausal Stud; 1995 Sep; 40 Suppl 2():98-104. PubMed ID: 8574257
    [Abstract] [Full Text] [Related]

  • 31. Desogestrel versus gestodene in oral contraceptives: influence on the clinical and histomorphological features of benign breast disease.
    Di Lieto A, De Rosa G, Albano G, Pagnano AM, Campanile M, Terracciano L, Pontillo M, Cimmino E, Covelli A, Paladini A.
    Eur J Obstet Gynecol Reprod Biol; 1994 May 31; 55(1):71-83. PubMed ID: 7958144
    [Abstract] [Full Text] [Related]

  • 32. The effect of monophasic combinations of ethinyl estradiol and norethindrone on gonadotropins, androgens and sex hormone binding globulin: a randomized trial.
    Moutos D, Smith S, Zacur H.
    Contraception; 1995 Aug 31; 52(2):105-9. PubMed ID: 8536446
    [Abstract] [Full Text] [Related]

  • 33. Comparative study on the acceptability of two modern monophasic oral contraceptive preparations: 30 microgram ethinyl estradiol combined with 150 microgram desogestrel or 75 microgram gestodene.
    Zichella L, Sbrignadello C, Tomassini A, Di Lieto A, Montoneri C, Zarbo G, Mancone M, Pietrobattista P, Bertoli G, Perrone G.
    Adv Contracept; 1999 Aug 31; 15(3):191-200. PubMed ID: 11019950
    [Abstract] [Full Text] [Related]

  • 34. Efficacy on hyperandrogenism and safety of a new oral contraceptive biphasic formulation containing desogestrel.
    Volpe A, Silferi M, Mauri A, Deiana P, Angioni S, Grasso A, Genazzani AR.
    Eur J Obstet Gynecol Reprod Biol; 1994 Mar 15; 53(3):205-9. PubMed ID: 8200468
    [Abstract] [Full Text] [Related]

  • 35. A comparative study of the effects of the hemostatic system of two monophasic gestodene oral contraceptives containing 20 micrograms and 30 micrograms ethinylestradiol.
    Winkler UH, Schindler AE, Endrikat J, Düsterberg B.
    Contraception; 1996 Feb 15; 53(2):75-84. PubMed ID: 8838483
    [Abstract] [Full Text] [Related]

  • 36. Serum pharmacokinetics of orally administered desogestrel and binding of contraceptive progestogens to sex hormone-binding globulin.
    Bergink W, Assendorp R, Kloosterboer L, van Lier W, Voortman G, Qvist I.
    Am J Obstet Gynecol; 1990 Dec 15; 163(6 Pt 2):2132-7. PubMed ID: 2147817
    [Abstract] [Full Text] [Related]

  • 37. A clinical overview of a new triphasic contraceptive containing gestodene.
    Christie T.
    Int J Fertil; 1989 Sep 15; 34 Suppl():40-9. PubMed ID: 2576257
    [Abstract] [Full Text] [Related]

  • 38. A randomized controlled trial of second- versus third-generation oral contraceptives in the treatment of acne vulgaris.
    Rosen MP, Breitkopf DM, Nagamani M.
    Am J Obstet Gynecol; 2003 May 15; 188(5):1158-60. PubMed ID: 12748463
    [Abstract] [Full Text] [Related]

  • 39. Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris.
    Lucky AW, Henderson TA, Olson WH, Robisch DM, Lebwohl M, Swinyer LJ.
    J Am Acad Dermatol; 1997 Nov 15; 37(5 Pt 1):746-54. PubMed ID: 9366821
    [Abstract] [Full Text] [Related]

  • 40. Group comparison of serum ethinyl estradiol, SHBG and CBG levels in 83 women using two low-dose combination oral contraceptives for three months.
    Dibbelt L, Knuppen R, Jütting G, Heimann S, Klipping CO, Parikka-Olexik H.
    Contraception; 1991 Jan 15; 43(1):1-21. PubMed ID: 1825969
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.